Innoviva (INVA) Revenue Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 397.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 397.46% |
| Dec 31, 2025 | 1.07% |
| Sep 30, 2025 | 336.07% |
| Jun 30, 2025 | 276.23% |
| Mar 31, 2025 | 315.46% |
| Dec 31, 2024 | 7.69% |
| Sep 30, 2024 | -2.93% |
| Jun 30, 2024 | 340.59% |
| Mar 31, 2024 | -3.23% |
| Dec 31, 2023 | 44.73% |
| Sep 30, 2023 | -8.81% |
| Jun 30, 2023 | -76.85% |
| Mar 31, 2023 | -78.37% |
| Dec 31, 2022 | -75.99% |
| Sep 30, 2022 | -72.96% |
| Jun 30, 2022 | -69.15% |
| Mar 31, 2022 | -71.81% |
| Dec 31, 2021 | -76.86% |
| Sep 30, 2021 | 16.63% |
| Jun 30, 2021 | -74.08% |
| Mar 31, 2021 | -72.70% |
| Dec 31, 2020 | -80.65% |
| Sep 30, 2020 | 22.17% |
| Jun 30, 2020 | 10.47% |
| Mar 31, 2020 | 24.78% |
| Dec 31, 2019 | 20.32% |
| Sep 30, 2019 | 25.45% |
| Jun 30, 2019 | 25.45% |
| Mar 31, 2019 | 31.67% |
| Dec 31, 2018 | 51.79% |
| Sep 30, 2018 | 65.68% |
| Jun 30, 2018 | 84.65% |
| Mar 31, 2018 | 96.57% |
| Dec 31, 2017 | 112.16% |
| Sep 30, 2017 | 265.16% |
| Jun 30, 2017 | 297.27% |
| Mar 31, 2017 | 273.04% |
| Dec 31, 2016 | 209.36% |
| Sep 30, 2016 | 331.36% |
| Jun 30, 2016 | 190.69% |
| Mar 31, 2016 | 163.46% |
| Dec 31, 2015 | 29.74% |
| Sep 30, 2015 | 111.67% |
| Jun 30, 2015 | 173.12% |
| Mar 31, 2015 | -62.01% |
| Dec 31, 2014 | 10.73% |
| Sep 30, 2014 | -46.24% |
| Jun 30, 2014 | -47.32% |
| Mar 31, 2014 | -50.24% |